Injection Pen Market

Injection Pen Market (Type: Reusable and Disposable; and Indication: Diabetes, Growth Hormone Therapy, Autoimmune, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Injection Pen Market Outlook 2031

  • The industry was valued at US$ 39.8 Bn in 2022
  • It is estimated to grow at a CAGR of 7.2% from 2023 to 2031 and reach US$ 73.7 Bn by the end of 2031

Analyst Viewpoint

High prevalence of diabetes and rise in preference for self-administration are fueling the injection pen market size. Injection pens that provide audible and visual feedback to confirm dose delivery are gaining traction among end-users.

Advanced injection pen technology has been continuously evolving to improve patient comfort and minimize pain during injections. Manufacturers are closely working on including ease of cartilage replacement, injection convenience, insulin-dose setting dial use, and prominence of audio clicks.

These factors are anticipated to improve the performance and quality of insulin injection pens, thereby augmenting the injection pen market development.

Market Introduction

Injection pen is a device that is extensively employed to deliver medicine, making the administration more convenient and easier. These pens are preferred over vials and syringes as they enable the delivery of the medicine in shorter intervals of time.

Disposable and reusable are two types of injection pens used for the administration of medicines. Disposable pens contain prefilled insulin cartridges, which are disposed of after usage.

Reusable pens contain an insulin cartridge, which can be replaced once the dose has been administered. Injection pens are employed in the effective treatment of a broad spectrum of medical conditions including diabetes, rheumatoid arthritis, obesity, and insulin deficiency.

Attribute Detail
Drivers
  • High Prevalence of Diabetes
  • Rise in Preference for Self-administration

High Prevalence of Diabetes Fueling Injection Pen Market Value

Injection pens are extensively used by over half of the patient population suffering from insulin-related problems. These pens are an easier and more convenient option for diabetic patients.

According to a 2019 Organization for Economic Co-operation and Development (OECD) report, nearly one in three adults is obese in Britain, the highest rate in Europe.

Injection pen manufacturers are introducing products with color codes to enable patients to distinguish between various insulin formulations. This helps to reduce pen-selection errors considerably.

Approval and launch of obesity drugs are driving the injection pen market demand. In January 2024, Eli Lilly announced to launch Mounjaro drug against obesity and diabetes in the U.K. within weeks after winning clearance for pre-filling it into an injection pen.

Rise in Preference for Self-administration Boosting Market Progress

Insulin pen devices make it easier and less painful for patients to self-administer daily injections. The high precision and accuracy of the device enables physicians to fine-tune dosage. Insulin pens are easy to use, user-friendly, and highly accurate in insulin delivery.

Additionally, these pens are available in durable or pre-filled designs wherein an interchangeable insulin cartridge is used. The availability of a range of insulin formulations is expected to spur the injection pen market growth in the near future.

Advanced injection pen technology for painless injections is increasingly being used to treat diabetes worldwide and the trend is expected to continue during the forecast period.

The ease of grip provided by injection pens and in performing self-injection procedures has driven the adoption of injection pens over the past few years— an injection pen market trend that is likely to continue in the near future.

High Demand for Disposable Injection Pens

According to the latest injection pen market analysis, the disposable type segment accounted for a prominent share in 2022. Growth of the segment can be ascribed to the convenient usage, accurate delivery, and appropriate dosage system of disposable injection pens.

These pends offer multiple doses and result in less infection to patients. Disposable pens are more reliable with fixed prefilled medicines as compared to those with reusable ones.

Regional Outlook

Attribute Detail
Leading Region North America

North America dominated the global injection pen market share in 2022. Increase in patient burden suffering from diabetes and surge in adoption of injection pens in-home care settings are driving the market dynamics of the region. Presence of key players offering various injection pens used for autoimmune, growth hormone, and diabetes and pediatric patients is also fueling the injection pen industry statistics in North America.

Analysis of Key Players in Injection Pen Industry

Injection pen companies are focused on improving the design parameters of products. They are tapping into opportunities across Asia Pacific and North America to establish a solid foothold in these regions. Key players are increasing awareness regarding the benefits of injection pens to gain a competitive edge in the current market landscape.

Manufacturers are adopting outsourcing services to offer affordable products. In 2023, Civica, Inc. selected Ypsomed AG as the manufacturer and supplier of insulin dosing injector pens for the company’s affordable insulins.

Lilly, Novo Nordisk, Owen Mumford, Sanofi, F. Hoffman-La Roche Ltd., Merck KGaA, Haselmeier, Gerresheimer AG, BD, and AstraZeneca are key players operating in this market.

The injection pen market report highlights these companies in terms of parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Key Developments in Injection Pen Market

  • In January 2024, Lilly launched a website to enable people to directly order from the drugmaker including its weight-loss medicine Zepbound as well as connect people with obesity and other conditions with telehealth companies
  • In 2023, Novo Nordisk launched its weight-loss injection Wegovy in Britain in a bid to expand its presence in the region and keep up with rising demand

Injection Pen Market Snapshot

Attribute Detail
Market Value in 2022 (Base Year) US$ 39.8 Bn
Market Forecast Value in 2031 US$ 73.7 Bn
Growth Rate (CAGR) 7.2%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape
  • Prominent Players – Competition Dashboard and Revenue Share Analysis, 2022
  • Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Format Electronic (PDF) + Excel
Market Segmentation
  • Туре
    • Reusable
    • Disposable
  • Indication
    • Diabetes
    • Growth Hormone Therapy
    • Autoimmune
    • Others
  • Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
Regions Covered
  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia & CIS
  • China
  • India
  • Japan
  • ASEAN
  • Brazil
  • Mexico
  • South Africa
Companies Profiled
  • Lilly
  • Novo Nordisk
  • Owen Mumford
  • Sanofi
  • F. Hoffman-La Roche Ltd.
  • Merck KGaA
  • Haselmeier
  • Gerresheimer AG
  • BD
  • AstraZeneca
Customization Scope Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the injection pen market in 2022?

It was valued at US$ 39.8 Bn in 2022

How is the injection pen industry expected to grow during the forecast period?

It is projected to grow at a CAGR of 7.2% from 2023 to 2031

What are the key factors driving the demand for injection pens?

High prevalence of diabetes and rise in preference for self-administration

Which was the prominent type segment in the injection pen sector in 2022?

The disposable segment dominated in 2022

Which region was the most lucrative in the injection pen business in 2022?

North America was the most lucrative region in 2022

Who are the prominent injection pen manufacturers?

Lilly, Novo Nordisk, Owen Mumford, Sanofi, F. Hoffman-La Roche Ltd., Merck KGaA, Haselmeier, Gerresheimer AG, BD, and AstraZeneca

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Injection Pen Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Injection Pen Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Injection Pen Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Type, 2017–2031

        6.3.1. Reusable

        6.3.2. Disposable

    6.4. Market Attractiveness Analysis, by Type

7. Global Injection Pen Market Analysis and Forecast, by Indication

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Indication, 2017–2031

        7.3.1. Diabetes

        7.3.2. Growth Hormone Therapy

        7.3.3. Autoimmune

        7.3.4. Others

    7.4. Market Attractiveness Analysis, by Indication

8. Global Injection Pen Market Analysis and Forecast, by Distribution Channel

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Distribution Channel, 2017–2031

        8.3.1. Hospital Pharmacies

        8.3.2. Retail Pharmacies

        8.3.3. Online Pharmacies

    8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Injection Pen Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2017–2031

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Injection Pen Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Type, 2017–2031

        10.3.1. Reusable

        10.3.2. Disposable

    10.4. Market Value Forecast, by Indication, 2017–2031

        10.4.1. Diabetes

        10.4.2. Growth Hormone Therapy

        10.4.3. Autoimmune

        10.4.4. Others

    10.5. Market Value Forecast, by Distribution Channel, 2017–2031

        10.5.1. Hospital Pharmacies

        10.5.2. Retail Pharmacies

        10.5.3. Online Pharmacies

    10.6. Market Value Forecast, by Country, 2017–2031

        10.6.1. U.S.

        10.6.2. Canada

    10.7. Market Attractiveness Analysis

        10.7.1. By Type

        10.7.2. By Indication

        10.7.3. By Distribution Channel

        10.7.4. By Country

11. Europe Injection Pen Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Type, 2017–2031

        11.3.1. Reusable

        11.3.2. Disposable

    11.4. Market Value Forecast, by Indication, 2017–2031

        11.4.1. Diabetes

        11.4.2. Growth Hormone Therapy

        11.4.3. Autoimmune

        11.4.4. Others

    11.5. Market Value Forecast, by Distribution Channel, 2017–2031

        11.5.1. Hospital Pharmacies

        11.5.2. Retail Pharmacies

        11.5.3. Online Pharmacies

    11.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.6.1. Germany

        11.6.2. U.K.

        11.6.3. France

        11.6.4. Italy

        11.6.5. Spain

        11.6.6. Rest of Europe

    11.7. Market Attractiveness Analysis

        11.7.1. By Type

        11.7.2. By Indication

        11.7.3. By Distribution Channel

        11.7.4. By Country/Sub-region

12. Asia Pacific Injection Pen Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Type, 2017–2031

        12.3.1. Reusable

        12.3.2. Disposable

    12.4. Market Value Forecast, by Indication, 2017–2031

        12.4.1. Diabetes

        12.4.2. Growth Hormone Therapy

        12.4.3. Autoimmune

        12.4.4. Others

    12.5. Market Value Forecast, by Distribution Channel, 2017–2031

        12.5.1. Hospital Pharmacies

        12.5.2. Retail Pharmacies

        12.5.3. Online Pharmacies

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. China

        12.6.2. Japan

        12.6.3. India

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Market Attractiveness Analysis

        12.7.1. By Type

        12.7.2. By Indication

        12.7.3. By Distribution Channel

        12.7.4. By Country/Sub-region

13. Latin America Injection Pen Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Type, 2017–2031

        13.3.1. Reusable

        13.3.2. Disposable

    13.4. Market Value Forecast, by Indication, 2017–2031

        13.4.1. Diabetes

        13.4.2. Growth Hormone Therapy

        13.4.3. Autoimmune

        13.4.4. Others

    13.5. Market Value Forecast, by Distribution Channel, 2017–2031

        13.5.1. Hospital Pharmacies

        13.5.2. Retail Pharmacies

        13.5.3. Online Pharmacies

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. Brazil

        13.6.2. Mexico

        13.6.3. Rest of Latin America

    13.7. Market Attractiveness Analysis

        13.7.1. By Type

        13.7.2. By Indication

        13.7.3. By Distribution Channel

        13.7.4. By Country/Sub-region

14. Middle East & Africa Injection Pen Market Analysis and Forecast

    14.1. Introduction

    14.2. Key Findings

    14.3. Market Value Forecast, by Type, 2017–2031

        14.3.1. Reusable

        14.3.2. Disposable

    14.4. Market Value Forecast, by Indication, 2017–2031

        14.4.1. Diabetes

        14.4.2. Growth Hormone Therapy

        14.4.3. Autoimmune

        14.4.4. Others

    14.5. Market Value Forecast, by Distribution Channel, 2017–2031

        14.5.1. Hospital Pharmacies

        14.5.2. Retail Pharmacies

        14.5.3. Online Pharmacies

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. GCC Countries

        14.6.2. South Africa

        14.6.3. Rest of Middle East & Africa

    14.7. Market Attractiveness Analysis

        14.7.1. By Type

        14.7.2. By Indication

        14.7.3. By Distribution Channel

        14.7.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    15.2. Market Share Analysis, by Company (2022)

    15.3. Company Profiles

        15.3.1. Lilly

            15.3.1.1. Company Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Financial Overview

            15.3.1.5. Strategic Overview

        15.3.2. Novo Nordisk

            15.3.2.1. Company Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Financial Overview

            15.3.2.5. Strategic Overview

        15.3.3. Owen Mumford

            15.3.3.1. Company Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Financial Overview

            15.3.3.5. Strategic Overview

        15.3.4. Sanofi

            15.3.4.1. Company Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Financial Overview

            15.3.4.5. Strategic Overview

        15.3.5. F. Hoffman-La Roche Ltd.

            15.3.5.1. Company Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Financial Overview

            15.3.5.5. Strategic Overview

        15.3.6. AstraZeneca

            15.3.6.1. Company Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Financial Overview

            15.3.6.5. Strategic Overview

        15.3.7. Merck KGaA

            15.3.7.1. Company Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Financial Overview

            15.3.7.5. Strategic Overview

        15.3.8. Haselmeier

            15.3.8.1. Company Overview

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Financial Overview

            15.3.8.5. Strategic Overview

        15.3.9. Gerresheimer AG

            15.3.9.1. Company Overview

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Financial Overview

            15.3.9.5. Strategic Overview

        15.3.10. BD

            15.3.10.1. Company Overview

            15.3.10.2. Product Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Financial Overview

            15.3.10.5. Strategic Overview

List of Tables

Table 01: Global Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 03: Global Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 04: Global Injection Pen Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Injection Pen Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 07: North America Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 08: North America Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 09: Europe Injection Pen Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 11: Europe Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 12: Europe Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 13: Asia Pacific Injection Pen Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 15: Asia Pacific Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 16: Asia Pacific Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 17: Latin America Injection Pen Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 19: Latin America Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 20: Latin America Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 21: Middle East & Africa Injection Pen Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 23: Middle East & Africa Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 24: Middle East & Africa Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

List of Figures

Figure 01: Global Injection Pen Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

Figure 02: Global Injection Pen Market Revenue (US$ Mn), by Type, 2022

Figure 03: Global Injection Pen Market Value Share, by Type, 2022

Figure 04: Global Injection Pen Market Revenue (US$ Mn), by Indication, 2022

Figure 05: Global Injection Pen Market Value Share, by Indication, 2022

Figure 06: Global Injection Pen Market Revenue (US$ Mn), by Distribution Channel, 2022

Figure 07: Global Injection Pen Market Value Share, by Distribution Channel, 2022

Figure 08: Global Injection Pen Market Value Share, by Region, 2022

Figure 09: Global Injection Pen Market Value (US$ Mn) Forecast, 2023–2031

Figure 10: Global Injection Pen Market Value Share Analysis, by Type, 2022–2031

Figure 11: Global Injection Pen Market Attractiveness Analysis, by Type, 2023–2031

Figure 12: Global Injection Pen Market Value Share Analysis, by Indication, 2022–2031

Figure 13: Global Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031

Figure 14: Global Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031

Figure 15: Global Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 16: Global Injection Pen Market Value Share Analysis, by Region, 2022–2031

Figure 17: Global Injection Pen Market Attractiveness Analysis, by Region, 2023–2031

Figure 18: North America Injection Pen Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 19: North America Injection Pen Market Attractiveness Analysis, by Country, 2023–2031

Figure 20: North America Injection Pen Market Value Share Analysis, by Country, 2022–2031

Figure 21: North America Injection Pen Market Value Share Analysis, by Type, 2022–2031

Figure 22: North America Injection Pen Market Value Share Analysis, by Indication, 2022–2031

Figure 23: North America Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031

Figure 24: North America Injection Pen Market Attractiveness Analysis, by Type, 2023–2031

Figure 25: North America Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031

Figure 26: North America Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 27: Europe Injection Pen Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 28: Europe Injection Pen Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 29: Europe Injection Pen Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 30: Europe Injection Pen Market Value Share Analysis, by Type, 2022–2031

Figure 31: Europe Injection Pen Market Value Share Analysis, by Indication, 2022–2031

Figure 32: Europe Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031

Figure 33: Europe Injection Pen Market Attractiveness Analysis, by Type, 2023–2031

Figure 34: Europe Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031

Figure 35: Europe Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 36: Asia Pacific Injection Pen Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 37: Asia Pacific Injection Pen Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 38: Asia Pacific Injection Pen Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 39: Asia Pacific Injection Pen Market Value Share Analysis, by Type, 2022–2031

Figure 40: Asia Pacific Injection Pen Market Value Share Analysis, by Indication, 2022–2031

Figure 41: Asia Pacific Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031

Figure 42: Asia Pacific Injection Pen Market Attractiveness Analysis, by Type, 2023–2031

Figure 43: Asia Pacific Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031

Figure 44: Asia Pacific Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 45: Latin America Injection Pen Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 46: Latin America Injection Pen Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 47: Latin America Injection Pen Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 48: Latin America Injection Pen Market Value Share Analysis, by Type, 2022–2031

Figure 49: Latin America Injection Pen Market Value Share Analysis, by Indication, 2022–2031

Figure 50: Latin America Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031

Figure 51: Latin America Injection Pen Market Attractiveness Analysis, by Type, 2023–2031

Figure 52: Latin America Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031

Figure 53: Latin America Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 54: Middle East & Africa Injection Pen Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 55: Middle East & Africa Injection Pen Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 56: Middle East & Africa Injection Pen Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 57: Middle East & Africa Injection Pen Market Value Share Analysis, by Type, 2022–2031

Figure 58: Middle East & Africa Injection Pen Market Value Share Analysis, by Indication, 2022–2031

Figure 59: Middle East & Africa Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031

Figure 60: Middle East & Africa Injection Pen Market Attractiveness Analysis, by Type, 2023–2031

Figure 61: Middle East & Africa Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031

Figure 62: Middle East & Africa Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved